Loading...
Immediate Reactions After the First Dose of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Messenger RNA Vaccines Do Not Preclude Second-Dose Administration
Addressing coronavirus disease 2019 (COVID-19) vaccine hesitancy and minimizing potential vaccine contraindications are critical to combatting the pandemic. We describe a practical approach to immediate adverse events after the first dose of messenger RNA vaccines for severe acute respiratory syndro...
Na minha lista:
| Udgivet i: | Clin Infect Dis |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8194535/ https://ncbi.nlm.nih.gov/pubmed/33989390 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciab448 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|